Axiom Investment Management LLC Gilead Sciences, Inc. Transaction History

Axiom Investment Management LLC

$38.4 Million
Q4 2022

A detailed history of Axiom Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Axiom Investment Management LLC holds 7,195 shares of GILD stock, worth $648,917. This represents 1.61% of its overall portfolio holdings.

Number of Shares

7,195

Previous 11,014 34.67%

Holding current value

$648,917

Previous $679,000 9.13%

% of portfolio

1.61%

Previous 1.36%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $238,000 - $341,685	-3,819 Reduced 34.67%	7,195 $617,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $133,905 - $152,954	-2,249 Reduced 16.96%	11,014 $679,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2.62 Million - $2.95 Million	-45,445 Reduced 77.41%	13,263 $819,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $235,328 - $294,892	-4,063 Reduced 6.47%	58,708 $3.49 Million
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $642,701 - $729,477	-9,906 Reduced 13.63%	62,771 $4.56 Million
Q3 2021 Oct 18, 2021	BUY	$67.69 - $73.03 $158,191 - $170,671	2,337 Added 3.32%	72,677 $5.08 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.09 Million - $1.19 Million	17,207 Added 32.38%	70,340 $4.84 Million
Q1 2021 May 20, 2021	SELL	$60.0 - $68.46 $1.28 Million - $1.47 Million	-21,405 Reduced 28.72%	53,133 $3.44 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $4.44 Million - $5.07 Million	74,016 Added 14179.31%	74,538 $4.82 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $29,571 - $33,695	522 New	522 $1.21 Million
Q2 2020 Mar 16, 2021	SELL	$72.34 - $84.0 $227,292 - $263,928	-3,142 Closed	0 $0
Q1 2020 Mar 16, 2021	BUY	$62.63 - $80.22 $196,783 - $252,051	3,142 New	3,142 $236,000
Q4 2019 Mar 16, 2021	SELL	$61.62 - $67.78 $202,853 - $223,131	-3,292 Closed	0 $0
Q3 2019 Mar 16, 2021	SELL	$62.51 - $69.0 $247,477 - $273,171	-3,959 Reduced 54.6%	3,292 $208,000
Q2 2019 Mar 16, 2021	SELL	$61.87 - $69.38 $36,255 - $40,656	-586 Reduced 7.48%	7,251 $491,000
Q1 2019 Mar 16, 2021	BUY	$62.53 - $70.05 $94,232 - $105,565	1,507 Added 23.81%	7,837 $510,000
Q4 2018 Oct 23, 2020	BUY	$60.54 - $79.0 $383,218 - $500,070	6,330 New	6,330 $396,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investment Management LLC with notifications on news.

Account

Axiom Investment Management LLC Gilead Sciences, Inc. Transaction History